These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28756272)

  • 1. Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions.
    Lalu L; Tambe V; Pradhan D; Nayak K; Bagchi S; Maheshwari R; Kalia K; Tekade RK
    J Control Release; 2017 Dec; 268():19-39. PubMed ID: 28756272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
    Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
    J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidimensional Ophthalmic Nanosystems for Molecular Detection and Therapy of Eye Disorders.
    Vyas S; Kakade P; Chogale M; Disouza J; Patravale V
    Curr Pharm Des; 2015; 21(22):3223-38. PubMed ID: 26027563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
    Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
    Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-based strategies for treatment of ocular disease.
    Weng Y; Liu J; Jin S; Guo W; Liang X; Hu Z
    Acta Pharm Sin B; 2017 May; 7(3):281-291. PubMed ID: 28540165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
    Wu KY; Wang XC; Anderson M; Tran SD
    Molecules; 2024 May; 29(10):. PubMed ID: 38792122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent perspectives for corticosteroids based ophthalmic therapeutics.
    Suresh PK; Sah AK
    Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.
    Suresh PK; Sah AK
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1747-68. PubMed ID: 25007007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
    López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
    Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent updates on ocular disease management with ophthalmic ointments.
    Bisen AC; Dubey A; Agrawal S; Biswas A; Rawat KS; Srivastava S; Bhatta RS
    Ther Deliv; 2024; 15(6):463-480. PubMed ID: 38888757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology in ocular delivery: current and future directions.
    Sultana Y; Maurya DP; Iqbal Z; Aqil M
    Drugs Today (Barc); 2011 Jun; 47(6):441-55. PubMed ID: 21695286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-based eye drop: Topical and noninvasive therapy for ocular diseases.
    Wang C; Pang Y
    Adv Drug Deliv Rev; 2023 Mar; 194():114721. PubMed ID: 36773886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption enhancement strategies in chitosan-based nanosystems and hydrogels intended for ocular delivery: Latest advances for optimization of drug permeation.
    Dmour I
    Carbohydr Polym; 2024 Nov; 343():122486. PubMed ID: 39174104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.